Skip to main content
. 2019 Jul 4;10:479. doi: 10.3389/fpsyt.2019.00479

Figure 2.

Figure 2

Associations of anxiety symptomatology and obesity with testosterone and estradiol levels in premenopausal and postmenopausal women. (A) Total testosterone levels, (B) free testosterone levels, (C) estradiol levels, (D) composition of total testosterone with estradiol levels, and (E) composition of free testosterone with estradiol levels. Significant differences are marked with * (p between 0.05 and 0.01), ** (p between 0.01 and 0.001), and *** (p < 0.001). Abbreviations: NA, non-anxious (anxiety symptomatology not present = GAD-7 < 10 points); A, anxious (anxiety symptomatology present = GAD-7 ≥ 10 points); NW, normal weight (BMI between 18.5 and 25 kg/m2); O, obese (BMI ≥ 30 kg/m2).